Alternate LDL Measures: Outcomes Tell the Story

Be part of the knowledge.

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Alternate LDL Measures: Outcomes Tell the Story

Dr. Cromwell talks about LDL-P and apo B values within the context of discordance with LDL-C values, as well as management for improved outcomes.
  • Sponsored by

  • Overview

    Ample data have demonstrated when LDL cholesterol and alternative measures – LDL-P or apo B – disagree, the risk for CVD events tracks with LDL-P or apo B. Additionally, it’s been demonstrated that when patients at high risk for CVD events were managed with the alternative measure LDL-P to 1,000 nmol/L versus less than 100 mg/dL, these patients experienced a 22 percent to 25 percent reduction in CVD events at 12, 24 and 36 months. Importantly, only a small number of individuals needed to be treated to an LDL-P of less than 1000 nmol/L to prevent one CVD event at 36 months. 

    Dr. William Cromwell, medical director for cardiovascular disease at LabCorp, will address these issues.

    Click here to learn more in this special series.



Facebook Comments

You must be in to display playlists.

Get a Dose of ReachMD in Your Inbox
and Practice Smarter Medicine

Stay current with the best in medical education.